Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ANRO · NYSE · Pharmaceutical Preparations
$25.37−1.14 (−4.30%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Alto Neuroscience (ANRO) · oqro.io/stocks/ANRO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 16, 2026 · Filed Nov 19, 2026
Officer sold ~$1.55M of ANRO shares in the open marketSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 19, 2026
Officer sold ~$310K of ANRO shares in the open marketSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 19, 2026
Officer sold ~$78K of ANRO shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 19, 2026
Officer sold ~$77K of ANRO shares in the open marketSourceInsider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Officer sold ~$56K of ANRO shares in the open marketSourcePlanned sale · Planned for Nov 16, 2026 · Notice filed Nov 16, 2026
Officer filed to sell about $2.22M of ANRO stockSourceInsider trade · Traded Sep 29, 2026 · Filed Oct 2, 2026
CFO sold ~$2.95M of ANRO shares in the open marketSourceInsider trade · Traded Sep 30, 2026 · Filed Oct 2, 2026
CFO sold ~$597K of ANRO shares in the open marketSourceInsider trade · Traded Sep 30, 2026 · Filed Oct 2, 2026
CFO sold ~$24K of ANRO shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed a reduced position in ANRO for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC disclosed an increased position in ANRO for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed an increased position in ANRO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Ra Capital Management, L.P. no longer reported ANRO for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 12, 2024
Valor Management LLC no longer reported ANRO for Q3 2024Source